Cargando…
H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone
Giant cell tumor of bone (GCTB) is a locally aggressive subarticular tumor. Having recently reported that H3.3 G34W mutations are characteristic of this tumor type, we have now investigated the sensitivity and specificity of the anti-histone H3.3 G34W rabbit monoclonal antibody in a wide variety of...
Autores principales: | Amary, Fernanda, Berisha, Fitim, Ye, Hongtao, Gupta, Manu, Gutteridge, Alice, Baumhoer, Daniel, Gibbons, Rebecca, Tirabosco, Roberto, O’Donnell, Paul, Flanagan, Adrienne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health, Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510691/ https://www.ncbi.nlm.nih.gov/pubmed/28505000 http://dx.doi.org/10.1097/PAS.0000000000000859 |
Ejemplares similares
-
Synovial chondromatosis and soft tissue chondroma: extra-osseous cartilaginous tumours defined by FN1 gene rearrangement
por: Amary, Fernanda, et al.
Publicado: (2019) -
Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast‐rich mimics
por: Presneau, Nadège, et al.
Publicado: (2015) -
Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma
por: Cottone, Lucia, et al.
Publicado: (2020) -
Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detection
por: Gutteridge, Alice, et al.
Publicado: (2017) -
Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy
por: Fernanda Amary, M, et al.
Publicado: (2014)